AMD stands for age-related macular degeneration, a progressive eye condition that damages the macula, the small central area of the retina responsible for sharp, detailed vision. It’s the leading cause of significant vision loss in adults over 50, and globally, about 8 million people had vision impairment from AMD as of 2021, a number projected to reach 21 million by 2050. AMD doesn’t cause total blindness, but it can severely compromise the central vision you rely on for reading, driving, and recognizing faces.
How AMD Damages Your Vision
The macula sits at the center of the retina and handles fine-detail tasks. Beneath the macula is a layer of cells called the retinal pigment epithelium (RPE), which nourishes and maintains the light-sensitive photoreceptors above it. In AMD, this support system breaks down.
The process typically starts with the buildup of drusen, tiny yellowish waste deposits that accumulate between the RPE and its blood supply. Small drusen are common with aging and often harmless. But as drusen grow larger and more numerous, they interfere with the flow of oxygen and nutrients to the retina. This starves the RPE cells, which begin to malfunction and die. When enough RPE cells are lost, the photoreceptors they support also die, and vision in that area goes dark.
The immune system plays a role too. Drusen attract immune cells that attempt to clear the debris, but their sustained presence triggers chronic inflammation. That inflammation can accelerate RPE damage and, in some cases, stimulate the growth of abnormal blood vessels that characterize the more aggressive form of the disease.
Dry AMD vs. Wet AMD
Most people with AMD have the dry form, where the macula gradually thins as RPE cells and photoreceptors die off. Dry AMD progresses slowly, often over years or decades, and vision loss tends to be gradual. There is no sudden event. Instead, your central vision slowly becomes less sharp.
Wet AMD is less common but far more urgent. It occurs when abnormal blood vessels grow from beneath the retina into the macula. These vessels are fragile and leak fluid or blood, which can rapidly distort and destroy central vision. Any stage of dry AMD can convert to wet AMD, and wet AMD is always considered late-stage disease. The shift can happen quickly, which is why monitoring matters even if your dry AMD has been stable for years.
Stages of Progression
AMD is classified into early, intermediate, and late stages based on the size and number of drusen and the extent of RPE changes. In early AMD, medium-sized drusen are present but vision is typically unaffected. You likely wouldn’t notice anything wrong. Intermediate AMD involves larger drusen and pigment changes in the retina. Some people at this stage begin to notice mild blurriness or difficulty in low light.
Late AMD is where significant vision loss occurs. In the dry form, late-stage disease means widespread RPE and photoreceptor death (called geographic atrophy), creating patches of missing vision. In the wet form, it means those leaking abnormal blood vessels are actively damaging the macula. Both late-stage forms can severely impair central vision, though peripheral vision usually remains intact.
What AMD Vision Loss Feels Like
The hallmark symptom is a dimming, fuzziness, or blank spot in the center of your visual field. You might notice that text looks blurry even with the right glasses, or that a face across the table seems slightly out of focus. Colors may appear less vivid.
Wet AMD often announces itself differently. Straight lines, like door frames or the edges of a bookshelf, start to appear wavy or curved. Objects may look smaller or warped. A dark or empty patch can appear in the center of your vision seemingly overnight. These are signs that fluid is accumulating beneath or within the retina and distorting its surface.
Risk Factors: Genetics and Smoking
Age is the strongest risk factor, with the condition rarely appearing before 50 and becoming increasingly common after 60. But two other factors stand out in the research: genetics and smoking.
A specific variation in the complement factor H (CFH) gene is one of the strongest genetic risk factors identified. This gene helps regulate part of the immune system, and people who carry certain CFH mutations have a significantly elevated risk. However, the genetic predisposition alone may not be enough. Animal studies show that CFH deficiency without additional stressors doesn’t reliably produce retinal damage on its own.
Smoking is the single most important preventable risk factor. It increases the risk of developing AMD by two to four times. Worse, smoking and CFH mutations appear to work together. Research shows that when both factors are present, retinal damage develops faster and more severely than either factor would produce alone. Smoking triggers oxidative stress and activates immune cells in the retina, and in people with genetic susceptibility, this combination accelerates the entire disease process. Eliminating tobacco use globally could prevent an estimated 19 million cases of AMD-related vision impairment by 2050.
How AMD Is Diagnosed
An eye doctor can detect AMD during a dilated eye exam, often before you notice any symptoms. The drusen deposits are visible when examining the retina.
Optical coherence tomography (OCT) is the key imaging tool. It creates a detailed cross-sectional scan of the retina, allowing your doctor to measure retinal thickness and spot fluid accumulation beneath or within the retinal layers. The scan produces a color-coded thickness map: warmer colors indicate thicker areas (potential swelling), cooler colors indicate thinner areas (potential cell loss). Central retinal thickness correlates with visual acuity, making it a reliable way to track how the disease is affecting your vision over time. The presence of subretinal fluid on OCT is a telltale sign of active wet AMD and often the trigger for starting treatment.
Treatment for Wet AMD
Wet AMD is treated with injections into the eye that block a protein called vascular endothelial growth factor (VEGF), the signal that drives abnormal blood vessel growth. These injections can stop the leaking vessels, reduce fluid buildup, and in many cases stabilize or even improve vision.
Treatment typically starts with a loading phase of monthly injections for the first three months. After that, the schedule varies. Some people continue monthly injections, while others move to a “treat and extend” approach where the interval between injections is gradually lengthened, sometimes to every eight or ten weeks, as long as the retina stays dry on OCT scans. If fluid returns, the interval is shortened again. Most people with wet AMD need ongoing treatment for years.
The injections themselves are quick. Numbing drops are applied first, and while the idea of a needle in the eye sounds alarming, most patients report only brief pressure or mild discomfort. The procedure takes just a few minutes in a clinic setting.
Slowing Dry AMD With Nutrition
There is no treatment that reverses dry AMD, but a specific supplement formula can slow its progression in people with intermediate or late-stage disease. The AREDS2 formula, developed through clinical trials funded by the National Eye Institute, contains 500 mg of vitamin C, 400 IU of vitamin E, 10 mg of lutein, 2 mg of zeaxanthin, 80 mg of zinc, and 2 mg of copper (added to prevent zinc-related copper deficiency). An earlier version included beta-carotene, but that was removed because it increases lung cancer risk in smokers.
These supplements are not beneficial for people with early AMD or no AMD at all. They’re specifically targeted at reducing the risk of progressing from intermediate to late-stage disease.
Monitoring at Home With an Amsler Grid
If you’ve been diagnosed with AMD, your eye doctor will likely give you an Amsler grid, a simple square of intersecting lines with a dot in the center. The routine is straightforward: hold the grid at normal reading distance (12 to 15 inches), wear your usual glasses or contacts, cover one eye, and focus on the center dot. Without moving your eye from that dot, check that all four corners are visible, all lines appear straight, no areas look dark or blank, and no lines are blurry or faded. Then repeat with the other eye.
Daily use is recommended. The grid is designed to catch the earliest signs of wet AMD conversion, particularly the waviness in straight lines that signals fluid is distorting your retina. If the grid suddenly looks different, that warrants a prompt call to your eye specialist, since early treatment of wet AMD produces better outcomes than delayed treatment.